CRISPR company Arbor Biotechnologies gets cash infusion from ARCH Feng Zhang spinoff has clearance to start gene editing clinical trial

https://www.statnews.com/2025/03/18/arbor-biotechnologies-crispr-feng-zhang-gets-cash-arch/